Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orphan Drugs Compose Majority Of Novel US Approvals For First Time Ever In 2018

Jan 03 2019

• By Michael Cipriano

The young chimney sweep in black and white - Image

Related Content

Gottlieb: Epidiolex Approval Covers One Specific Cannabidiol Medication, Not Marijuana

Jun 25 2018

Keeping Track: Tpoxx Wins Green Light For Smallpox, Submissions Galore, And A Broader Approval For Xtandi

Jul 16 2018

Breakthrough, Priority Review Designations Could Set High-Water Marks In 2018

Jul 06 2018

US FDA Sets Records With Breakthrough Therapy, Priority Review Designations In 2017

Jan 08 2018

CDER's 2017 New Drug Class Maintains Steady Innovative Composition With Recent Years

Jan 04 2018

US FDA’s Best Year Ever For New Drugs: CDER Novel Approvals Hit 59

Jan 01 2019

Related Companies

GW Pharmaceuticals plc

SIGA Technologies, Inc

Pfizer Inc.

Additional Topics

United States Approvals Drug Review Review Pathway Innovation Regulation BioPharmaceutical Pink Sheet Perspectives

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window